TABLE 3.
Peptide (aa) | aa sequencea | No. of SFC/106 cells
|
Haplotype (reference) | |
---|---|---|---|---|
BMC | PBMC | |||
Pol C poolb (201-310) | 760 | 2,150 | ||
P26 (251-270) | HPAGLKKKKSVTVLDVGDAY | 885 | ND | B35 (57) |
P27 (261-280) | VTVLDVGDAYFSVPLDEDFR | 1,410 | ND | B35 (57) |
P28 (271-290) | FSVPLDEDFRKYTAFTIPSI | 950 | ND | B51 (50) |
P29 (281-300) | KYTAFTIPSINNEETPGIRYQ | 860 | ND | B51 (50) |
Pol D poolb (301-410) | 1,375 | 2,175 | ||
P33 (321-340) | KILEPFRKQNPDIVIYQYMD | 1,305 | ND | B35 (42, 49) |
Nef B poolb (101-205) | 1,580 | 2,330 | ||
N14 (131-150) | GVRYPLTFGWCYKLVPVEPD | 1,825 | ND | B35 (49) |
N18 (171-190) | GMDDPEREVLEWRFDSRLAF | 1,595 | ND | A2 (17) |
Gag A poolb (1-110) | 590 | 355 | ||
G2 (11-30) | GELDRWEKIRLRPGGKKKYK | 490 | ND | A3 (14) |
G3 (21-40) | LRPGGKKKYKLKHIVWASRE | 420 | 600 | A3 (14) |
p17 Gag A3 (20-28) | RLRPGGKKK | ND | 620 | |
Medium | 175 | 25 |
Published epitope for the given HLA is underlined.
Each peptide pool contained 10 20-mers overlapping by 10 aa, covering the indicated region of HIV protein.